Skip to main content

Search
For Media

Press Releases

|

Personalized At-home Program Reduces Asthma Symptoms in Children

September 09, 2004

A program that targets allergens and tobacco smoke in the home resulted in fewer asthma symptoms in children participating in the intervention than in those who were not, according to a new study sponsored by the National Institutes of Health (NIH) in seven metropolitan areas nationwide. Children taking part in the intervention had 21 fewer days of asthma symptoms over the one-year course of intervention.

Seattle/Tacoma one of seven metropolitan areas to participate in the study

A program that targets allergens and tobacco smoke in the home resulted in fewer asthma symptoms in children participating in the intervention than in those who were not, according to a new study sponsored by the National Institutes of Health (NIH) in seven metropolitan areas nationwide. Children taking part in the intervention had 21 fewer days of asthma symptoms over the one-year course of intervention.

James Stout, M.D., M.P.H., researcher at Children’s Hospital and Regional Medical Center Associate Professor of Pediatrics and Adjunct Associate Professor in School of Public Health at the University of Washington School of Medicine and his research team studied children with asthma who lived in the Seattle-Tacoma area.

The study—co-funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Environmental Health Sciences (NIEHS), two NIH Institutes—appears in the September 9th issue of The New England Journal of Medicine.

“The burden that childhood asthma places on our society is enormous,” says Anthony S. Fauci, M.D., director of NIAID. “For the millions of children living with asthma, this important research demonstrates that taking practical steps can achieve long-term benefits in the form of better quality of life, fewer emergency room visits and lower healthcare costs.”

“These study results are exciting because they show that changes made in the home environment can produce a reduction in symptoms comparable to that achieved with asthma inhalers,” notes Kenneth Olden, Ph.D., director of NIEHS.
Asthma, a chronic lung disease characterized by coughing, wheezing and difficulty breathing, affects roughly 20 million Americans. Children who live in the inner city—in particular African-American and Hispanic children—suffer disproportionately from the disease. Increased asthma symptoms in this population may stem from exposure to high levels of multiple indoor allergens and tobacco smoke.

More than 900 children ages 5 to 11 with moderate to severe asthma participated in the study. Each participant had to be allergic to at least one common indoor environmental allergen, such as cockroach allergen or house dust mite allergen. The children, most of whom were African-American or Hispanic, lived in low-income sections of seven major metropolitan areas—the Bronx, Boston, Chicago, Dallas, Manhattan, Seattle/Tacoma and Tucson. Once accepted into the study, they were randomly assigned to either the intervention group or a control group.

Based on the child’s sensitivity to the selected indoor allergens and evidence of exposures at home to known asthma triggers, investigators designed an individualized environmental intervention, carried out by the child’s mother or another caretaker. The intervention focused on educating the family about ways to reduce or eliminate all allergens to which the child was allergic, as well as to reduce exposure to tobacco smoke, and motivating them to pursue these steps. The investigators developed separate interventions tailored to tobacco smoke and to the following allergens—house dust mite, cockroach, pet, rodent and mold.

In addition, families were given specific allergen-reducing measures, such as allergen-impermeable covers for children’s bedding and air purifiers with HEPA (high efficiency particulate air) filters, to be placed in key locations within their homes, including the children’s bedrooms. Cockroach extermination visits were provided for children who were allergic to cockroach allergens. During the first year of the study, the investigators conducted educational home visits with the families in the intervention group. Throughout the yearlong study and the one-year follow-up, researchers closely monitored all participants’ asthma symptoms and home allergen levels.

Children who participated in the intervention had significantly fewer asthma symptoms compared with those in the control group: an average of 21 fewer days of symptoms in the first year and an average of 16 fewer days during the second, or follow-up, year. In addition, the benefits of the intervention occurred rapidly: Investigators noted significant reductions in symptoms just 2 months after the study began.

The levels of cockroach and dust mite allergens in the children’s bedrooms in the intervention group were substantially lower than in the control group. Furthermore, the researchers noted a direct correlation between allergen levels and asthma symptoms for the children in the intervention group: The greater the drop in cockroach or house dust mite allergen levels, the greater the reduction in asthma symptoms, suggesting that the allergy-reducing measures made the difference.

Most previous environmental intervention studies focused on controlling a single allergen or tobacco smoke, and met with limited success.

This project is part of the Inner City Asthma Study, a cooperative multicenter initiative comprising seven asthma study centers across the country and a statistical center. The principal investigators are Wayne J. Morgan, M.D., University of Arizona College of Medicine, Tucson, first author on the paper; Ellen F. Crain, M.D., Ph.D., Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY; Richard Evans III, M.D., Children’s Memorial Hospital, Chicago, IL; Rebecca S. Gruchalla, M.D., Ph.D., University of Texas Southwestern Medical Center at Dallas, TX; Meyer Kattan, M.D., Mount Sinai School of Medicine, New York, NY; Herman Mitchell, Ph.D., Rho, Inc., Chapel Hill, NC; George T. O’Connor, M.D., Boston University School of Medicine, Boston, MA; and James W. Stout, M.D., M.P.H., University of Washington School of Medicine, Public Health and Children’s Hospital and Regional Medical Center, Seattle, WA.

About Seattle Children’s

Consistently ranked as one of the best children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical referral center for the largest landmass of any children’s hospital in the country (Washington, Alaska, Montana and Idaho). For more than 100 years, Seattle Children’s has been delivering superior patient care while advancing new treatments through pediatric research. Seattle Children’s serves as the primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine. The hospital works in partnership with Seattle Children’s Research Institute and Seattle Children’s Hospital Foundation. For more information, visit www.seattlechildrens.org or follow us on Twitter or Facebook.

Latest News

Vaccine Safety: Getting the Message to Parents in Doubt
8.28.14 — U.S. News & World Report

Measles, mumps and whooping cough have been around a long time – along with the vaccines to prevent them. But instead of being ... cont.

Depressed Teens May Need Extra Support To Stick With Treatment
8.27.14 — NPR

A new study from Seattle Children’s Research Institute suggests integrating mental health treatment into primary care may ... cont.

Can running cure depression? Seattle Children’s brain research finds exercise can help patients
8.26.14 — Puget Sound Business Journal

Researchers at Seattle Children’s Research Institute have pinpointed a tiny area of the brain that controls our motivation to ... cont.